US Stock MarketDetailed Quotes

Hoth Therapeutics (HOTH)

Watchlist
  • 0.8099
  • +0.0121+1.52%
Close Apr 24 16:00 ET
  • 0.8100
  • +0.0001+0.01%
Post 20:01 ET
15.49MMarket Cap-0.90P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hoth Therapeutics (HOTH) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
50.46%12.36M
23.88%2.61M
83.05%4.08M
27.67%2.2M
60.93%3.48M
3.30%8.22M
7.36%2.1M
6.51%2.23M
0.84%1.72M
-1.50%2.16M
Selling and administrative expenses
29.17%6.41M
21.30%1.29M
98.19%2.45M
7.51%1.16M
-4.46%1.52M
17.90%4.97M
35.83%1.06M
10.38%1.23M
2.14%1.08M
26.66%1.59M
-General and administrative expense
29.17%6.41M
21.30%1.29M
98.19%2.45M
7.51%1.16M
-4.46%1.52M
17.90%4.97M
35.83%1.06M
10.38%1.23M
2.14%1.08M
26.66%1.59M
Research and development costs
83.02%5.95M
26.53%1.31M
64.26%1.63M
61.44%1.04M
242.63%1.96M
-13.14%3.25M
-11.60%1.04M
2.06%994.47K
-1.25%644.03K
-39.11%571.64K
Operating profit
-50.46%-12.36M
-23.88%-2.61M
-83.05%-4.08M
-27.67%-2.2M
-60.93%-3.48M
-3.30%-8.22M
-7.36%-2.1M
-6.51%-2.23M
-0.84%-1.72M
1.50%-2.16M
Net non-operating interest income expense
Other net income (expense)
-497.88%-107.95K
-43,417.71%-83.17K
-12,668.50%-25.14K
-98.71%173
-98.65%181
117.72%27.13K
104.31%192
-96.87%200
108.13%13.37K
43.66%13.38K
Gain on sale of security
-489.54%-107.95K
-43,417.71%-83.17K
-12,668.50%-25.14K
-98.71%173
-98.70%181
117.59%27.71K
102.38%192
-96.44%200
108.13%13.37K
49.90%13.96K
Earnings from equity interest
--0
--0
--0
--0
--0
-113.20%-581
--0
--0
--0
---581
Income before tax
-52.28%-12.47M
-27.85%-2.69M
-84.20%-4.11M
-28.65%-2.2M
-61.93%-3.48M
-1.01%-8.19M
-7.11%-2.1M
-6.83%-2.23M
8.72%-1.71M
1.69%-2.15M
Income tax
Net income
-52.28%-12.47M
-27.85%-2.69M
-84.20%-4.11M
-28.65%-2.2M
-61.93%-3.48M
-1.01%-8.19M
-7.11%-2.1M
-6.83%-2.23M
8.72%-1.71M
1.69%-2.15M
Net income continuous Operations
-52.28%-12.47M
-27.85%-2.69M
-84.20%-4.11M
-28.65%-2.2M
-61.93%-3.48M
-1.01%-8.19M
-7.11%-2.1M
-6.83%-2.23M
8.72%-1.71M
1.69%-2.15M
Minority interest income
Net income attributable to the parent company
-52.28%-12.47M
-27.85%-2.69M
-84.20%-4.11M
-28.61%-2.2M
-61.93%-3.48M
-1.01%-8.19M
-7.11%-2.1M
-6.83%-2.23M
8.70%-1.71M
1.69%-2.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-52.28%-12.47M
-27.85%-2.69M
-84.20%-4.11M
-28.61%-2.2M
-61.93%-3.48M
-1.01%-8.19M
-7.11%-2.1M
-6.83%-2.23M
8.70%-1.71M
1.69%-2.15M
Basic earnings per share
29.69%-0.9
42.86%-0.16
6.25%-0.3
32.00%-0.17
44.90%-0.27
46.22%-1.28
28.21%-0.28
46.67%-0.32
56.14%-0.25
44.32%-0.49
Diluted earnings per share
29.69%-0.9
42.86%-0.16
6.25%-0.3
32.00%-0.17
44.90%-0.27
46.22%-1.28
28.21%-0.28
46.67%-0.32
56.14%-0.25
44.32%-0.49
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 50.46%12.36M23.88%2.61M83.05%4.08M27.67%2.2M60.93%3.48M3.30%8.22M7.36%2.1M6.51%2.23M0.84%1.72M-1.50%2.16M
Selling and administrative expenses 29.17%6.41M21.30%1.29M98.19%2.45M7.51%1.16M-4.46%1.52M17.90%4.97M35.83%1.06M10.38%1.23M2.14%1.08M26.66%1.59M
-General and administrative expense 29.17%6.41M21.30%1.29M98.19%2.45M7.51%1.16M-4.46%1.52M17.90%4.97M35.83%1.06M10.38%1.23M2.14%1.08M26.66%1.59M
Research and development costs 83.02%5.95M26.53%1.31M64.26%1.63M61.44%1.04M242.63%1.96M-13.14%3.25M-11.60%1.04M2.06%994.47K-1.25%644.03K-39.11%571.64K
Operating profit -50.46%-12.36M-23.88%-2.61M-83.05%-4.08M-27.67%-2.2M-60.93%-3.48M-3.30%-8.22M-7.36%-2.1M-6.51%-2.23M-0.84%-1.72M1.50%-2.16M
Net non-operating interest income expense
Other net income (expense) -497.88%-107.95K-43,417.71%-83.17K-12,668.50%-25.14K-98.71%173-98.65%181117.72%27.13K104.31%192-96.87%200108.13%13.37K43.66%13.38K
Gain on sale of security -489.54%-107.95K-43,417.71%-83.17K-12,668.50%-25.14K-98.71%173-98.70%181117.59%27.71K102.38%192-96.44%200108.13%13.37K49.90%13.96K
Earnings from equity interest --0--0--0--0--0-113.20%-581--0--0--0---581
Income before tax -52.28%-12.47M-27.85%-2.69M-84.20%-4.11M-28.65%-2.2M-61.93%-3.48M-1.01%-8.19M-7.11%-2.1M-6.83%-2.23M8.72%-1.71M1.69%-2.15M
Income tax
Net income -52.28%-12.47M-27.85%-2.69M-84.20%-4.11M-28.65%-2.2M-61.93%-3.48M-1.01%-8.19M-7.11%-2.1M-6.83%-2.23M8.72%-1.71M1.69%-2.15M
Net income continuous Operations -52.28%-12.47M-27.85%-2.69M-84.20%-4.11M-28.65%-2.2M-61.93%-3.48M-1.01%-8.19M-7.11%-2.1M-6.83%-2.23M8.72%-1.71M1.69%-2.15M
Minority interest income
Net income attributable to the parent company -52.28%-12.47M-27.85%-2.69M-84.20%-4.11M-28.61%-2.2M-61.93%-3.48M-1.01%-8.19M-7.11%-2.1M-6.83%-2.23M8.70%-1.71M1.69%-2.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -52.28%-12.47M-27.85%-2.69M-84.20%-4.11M-28.61%-2.2M-61.93%-3.48M-1.01%-8.19M-7.11%-2.1M-6.83%-2.23M8.70%-1.71M1.69%-2.15M
Basic earnings per share 29.69%-0.942.86%-0.166.25%-0.332.00%-0.1744.90%-0.2746.22%-1.2828.21%-0.2846.67%-0.3256.14%-0.2544.32%-0.49
Diluted earnings per share 29.69%-0.942.86%-0.166.25%-0.332.00%-0.1744.90%-0.2746.22%-1.2828.21%-0.2846.67%-0.3256.14%-0.2544.32%-0.49
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -